Clinical Trials Sponsored by Autistic Self Advocacy Network
Total 1 results
-
Oregon Health and Science UniversityNational Institute of Mental Health (NIMH); Indiana University; Syracuse University and other collaboratorsCompleted
Sponsors and Collaborators
- Hopeful Aging
- Marcus Vinícius Guimarães de Lacerda
- Genuv Inc.
- Pancreatic Cancer UK
- Biorobotic Institute Scuola Superiore sant'Anna Pisa
- Liming Cheng
- Egyptian Russian University
- Sahar Salehi
- Hoersholm Hospital
- Jia Liu
- Van Boven, Robert W., M.D.
- Friedrich Miescher Institute for Biomedical Research (FMI)
- The People's Hospital of Guangxi Zhang Autonomous Region
- Only For Children Pharmaceuticals
- Kerstyn C. Zalesin, M.D.
- FutureGen Biopharmaceutical (Beijing) Co., Ltd
- Xiao-Ming Mao
- Kuwait University
- Klinikum Bad Woerishofen
- Royal Hobart Hospital Research Foundation (funding source)
- View Full List
Medical Conditions
- Caffeine Dosage
- Pulmonary Invasive Aspergillosis
- Gait Variability; Elders; Fall; Re-education
- Stage II Vulvar Cancer
- Urinary Tract Carcinoma
- Raynaud Secondary to Other Autoimmune Disease
- Using Imagery to Maintain Muscle Mass Gains in the Quadriceps
- Advanced Gastric Cancer With Serosal Invasion
- Autologous Haematopoietic Stem Cell Transplant
- Role of Vitamin D in IVF for Better Outcome
- EHMT1
- Stereotype-threat
- High Perinatal Mortality
- Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia
- Pancytopenia Due to Chemotherapy
- Enlarged Uterus
- Smith-Lemli-Opitz Syndrome
- Secondary Hypertension to Endocrine Disorders
- Global Health
- Airway Obstruction
- View Full List
Drug Interventions
- ACP-204
- IBI318
- CAZ/AVI plus Aztreonam
- Clostridium Botulinum Toxin Type A (Nabota, DWP 450) 50 U
- Jatenzo
- Nystatin
- LX4211 800 mg
- P276-00
- Naltrexone and bupropion SR
- RDEA3170 12 mg
- APD334
- Vehicle Foam with UVA and UVB and visible light irradiation
- Omalizumab Injection
- Ustekinumab
- Androgen-deprivation Therapy (ADT)
- Iohexol Inj 300 MG/ML
- Ibudilast
- Olopatadine hydrochloride ophthalmic solution 0.7%)
- High-dose loop diuretics
- MC-1101
- View Full List
CROs by country
- Contract Research Organizations in Burkina Faso
- Contract Research Organizations in Djibouti
- Contract Research Organizations in Dominican Republic
- Contract Research Organizations in Georgia
- Contract Research Organizations in Japan
- Contract Research Organizations in Jordan
- Contract Research Organizations in Liberia
- Contract Research Organizations in Mauritania
- Contract Research Organizations in Russia
- Contract Research Organizations in Senegal
- Contract Research Organizations in Singapore
- Contract Research Organizations in Tanzania
- Contract Research Organizations in Zimbabwe
- CRO list by country